Logic-gated, allogeneic Tmod chimeric antigen receptor T-cell (CAR T) therapy targeting epidermal growth factor receptor (EGFR) in advanced solid tumors with human leukocyte antigen (HLA) loss of heterozygosity (LOH): DENALI-1 trial.

Authors: Kedar Kirtane, Jong Chul Park, Matthew Ulrickson, Deborah J.L. Wong, John B. Sunwoo, Julian R. Molina, David G. Maloney, Marcela Valderrama Maus, Harry E. Fuentes Bayne, Patrick Grierson, Salman Rafi Punekar, Frederick L. Locke, Marco L. Davila, Rebecca Arielle Shatsky, Wendy J. Langeberg, William Y. Go, Eric Wai-Choi Ng, John Sutton Welch, Joel R. Hecht, Jennifer M. Specht

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2677

Source: Full article

---

Abstract

TPS2677